検索結果 - Jan Steffel

結果の絞り込み
  1. 1
    Novel oral anticoagulants: focus on stroke prevention and treatment of venous thrombo-embolism

    Novel oral anticoagulants: focus on stroke prevention and treatment of venous thrombo-embolism 著者: Jan Steffel, Eugene Braunwald

    出版事項 2011
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  2. 2
    Superresponse to Cardiac Resynchronization Therapy

    Superresponse to Cardiac Resynchronization Therapy 著者: Jan Steffel, Frank Ruschitzka

    出版事項 2014
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  3. 3
    Sweet and Sour

    Sweet and Sour 著者: Thomas F. Lüscher, Jan Steffel

    出版事項 2008
    全文の入手 全文の入手
    Carta
    お気に入りに追加
    保存先:
  4. 4
    Tissue Factor in Cardiovascular Diseases

    Tissue Factor in Cardiovascular Diseases 著者: Jan Steffel, Thomas F. Lüscher, Felix C. Tanner

    出版事項 2006
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  5. 5
    Electrocardiographic Characteristics at Initial Diagnosis in Patients With Isolated Left Ventricular Noncompaction

    Electrocardiographic Characteristics at Initial Diagnosis in Patients With Isolated Left Ventricular Noncompaction 著者: Jan Steffel, Richard Kobza, Erwin Oechslin, Rolf Jenni, Fırat Duru

    出版事項 2009
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  6. 6
    Histamine Induces Tissue Factor Expression

    Histamine Induces Tissue Factor Expression 著者: Jan Steffel, Alexander Akhmedov, Helen Greutert, Thomas F. Lüscher, Felix C. Tanner

    出版事項 2005
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  7. 7
    Leadless pacemaker implantation via the internal jugular vein

    Leadless pacemaker implantation via the internal jugular vein 著者: Nadine Molitor, Shmaila Saleem‐Talib, Hemanth Ramanna, Daniel Höfer, Alexander Breitenstein, Jan Steffel

    出版事項 2024
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  8. 8
    Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy

    Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy 著者: S. Schmidt, David Hürlimann, Christoph Starck, G Hindricks, Thomas F. Lüscher, Frank Ruschitzka, Jan Steffel

    出版事項 2013
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  9. 9
    Epicardial left atrial appendage clip occlusion also provides the electrical isolation of the left atrial appendage

    Epicardial left atrial appendage clip occlusion also provides the electrical isolation of the left atrial appendage 著者: Christoph Starck, Jan Steffel, Maximilian Y. Emmert, André Plass, S. Mahapatra, Volkmar Falk, Sacha P. Salzberg

    出版事項 2012
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  10. 10
    The COMPASS Trial

    The COMPASS Trial 著者: Jan Steffel, John W. Eikelboom, Sonia S. Anand, Olga Shestakovska, Salim Yusuf, Keith A.A. Fox

    出版事項 2020
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  11. 11
    Celecoxib Decreases Endothelial Tissue Factor Expression Through Inhibition of c-Jun Terminal NH <sub>2</sub> Kinase Phosphorylation

    Celecoxib Decreases Endothelial Tissue Factor Expression Through Inhibition of c-Jun Terminal NH <sub>2</sub> Kinase Phosphorylation 著者: Jan Steffel, Matthias Hermann, Helen Greutert, Steffen Gay, Thomas F. Lüscher, Frank Ruschitzka, Felix C. Tanner

    出版事項 2005
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  12. 12
    Rapamycin, but Not FK-506, Increases Endothelial Tissue Factor Expression

    Rapamycin, but Not FK-506, Increases Endothelial Tissue Factor Expression 著者: Jan Steffel, Roberto Adriano Latini, Alexander Akhmedov, Dorothee Zimmermann, Pamela Zimmerling, Thomas F. Lüscher, Felix C. Tanner

    出版事項 2005
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  13. 13
    Drug-Eluting Stent and Coronary Thrombosis

    Drug-Eluting Stent and Coronary Thrombosis 著者: Thomas F. Lüscher, Jan Steffel, Franz R. Eberli, Michael Joner, Gaku Nakazawa, Felix C. Tanner, Renu Virmani

    出版事項 2007
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  14. 14
    The effects of continuous positive airway pressure therapy withdrawal on cardiac repolarization: data from a randomized controlled trial

    The effects of continuous positive airway pressure therapy withdrawal on cardiac repolarization: data from a randomized controlled trial 著者: Valentina A. Rossi, Anne‐Christin Stoewhas, Giovanni Camen, Jan Steffel, Konrad E. Bloch, John Stradling, Marianne Køhler

    出版事項 2012
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  15. 15
    Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling

    Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling 著者: Georg Fröhlich, Jan Steffel, David Hürlimann, Frank Enseleit, Thomas F. Lüscher, Frank Ruschitzka, William T. Abraham, Johannes Holzmeister

    出版事項 2010
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  16. 16
    Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents

    Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents 著者: Giovanni G. Camici, Jan Steffel, I. Amanovic, Alexander Breitenstein, Jeannette Baldinger, Stephan Sylvest Keller, Thomas F. Lüscher, Felix C. Tanner

    出版事項 2009
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  17. 17
    Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systematic review

    Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systemati... 著者: Neal A. Chatterjee, Attila Róka, Steven A. Lubitz, Michael R. Gold, Claude Daubert, Cecilia Linde, Jan Steffel, G. André Ng, Theofanie Mela

    出版事項 2015
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  18. 18
    Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial

    Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial 著者: Jan Steffel, Robert P. Giugliano, Eugene Braunwald, Sabina A. Murphy, Dan Atar, Hein Heidbüchel, A. John Camm, Elliott M. Antman, Christian T. Ruff

    出版事項 2015
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  19. 19
    Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation

    Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation 著者: Jan Steffel, Christian T. Ruff, Ophelia Yin, Eugene Braunwald, Jeong‐Gun Park, Sabina A. Murphy, Stuart J. Connolly, Elliott M. Antman, Robert P. Giugliano

    出版事項 2021
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  20. 20
    Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling

    Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling 著者: Jan Steffel, Robert P. Giugliano, Eugene Braunwald, Sabina A. Murphy, Michele Mercuri, Youngsook Choi, Philip E. Aylward, Harvey D. White, Josè Luis Zamorano, Elliott M. Antman, Christian T. Ruff

    出版事項 2016
    全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: